Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.24 USD | +3.28% | +15.66% | +79.35% |
03-21 | MediWound Ltd. Provides Revenue Guidance for the Year 2025 and 2026 | CI |
03-21 | Transcript : MediWound Ltd., Q4 2023 Earnings Call, Mar 21, 2024 |
Sales 2024 * | 24.04M 1.92B | Sales 2025 * | 31.94M 2.56B | Capitalization | 169M 13.52B |
---|---|---|---|---|---|
Net income 2024 * | -17M -1.36B | Net income 2025 * | -18M -1.44B | EV / Sales 2024 * | 7.02 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.29 x |
P/E ratio 2024 * |
-9.45
x | P/E ratio 2025 * |
-9.81
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.27% |
Latest transcript on MediWound Ltd.
1 day | +3.28% | ||
1 week | +15.66% | ||
Current month | +28.00% | ||
1 month | +17.22% | ||
3 months | +42.50% | ||
6 months | +133.85% | ||
Current year | +79.35% |
Managers | Title | Age | Since |
---|---|---|---|
Ofer Gonen
CEO | Chief Executive Officer | 49 | 31/08/03 |
Hani Luxenburg
DFI | Director of Finance/CFO | 52 | 13/05/23 |
Robert Snyder
CTO | Chief Tech/Sci/R&D Officer | 75 | 31/12/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Wills
BRD | Director/Board Member | 67 | 31/03/17 |
David Fox
BRD | Director/Board Member | 66 | 26/04/20 |
Homi Shamir
CHM | Chairman | 70 | 31/07/22 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 18.24 | +3.28% | 73,119 |
25/04/24 | 17.66 | +0.40% | 97,020 |
24/04/24 | 17.59 | +7.19% | 47,822 |
23/04/24 | 16.41 | +4.12% | 21,248 |
22/04/24 | 15.76 | -0.06% | 28,669 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+79.35% | 169M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |
- Stock Market
- Equities
- MDWD Stock